Investigation of the difference among long acting insulin products in type 1 diabetes

Trial Profile

Investigation of the difference among long acting insulin products in type 1 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms Best-Basal-Insulin-Study
  • Most Recent Events

    • 05 Jun 2015 Results published in the Diabetologia.
    • 19 Sep 2014 Primary endpoint (Standard deviation and coefficient of variation of fasting glucose level in the last week of treatment) has been met.
    • 19 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top